Detalhe da pesquisa
1.
Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following Prior Infection or Vaccination.
J Infect Dis
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38717928
2.
Assessing the post hoc effectiveness of tixagevimab-cilgavimab for prevention of SARS-CoV-2 infections in solid organ transplant recipients.
Transpl Infect Dis
; 26(1): e14182, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37885435
3.
Serological response to vaccination in post-acute sequelae of COVID.
BMC Infect Dis
; 23(1): 97, 2023 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36797666
4.
Monoclonal Antibodies as SARS-CoV-2 Serology Standards: Experimental Validation and Broader Implications for Correlates of Protection.
Int J Mol Sci
; 24(21)2023 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37958688
5.
Long-term durability of antibody responses after SARS-CoV-2 vaccination and influencing factors.
J Intern Med
; 293(4): 520-523, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36625223
6.
Specificity and Confirmation of SARS-CoV-2 Serological Test Methods in Emergency Department Populations Across the United States in 2019 and Early 2020.
J Appl Lab Med
; 2022 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35723951
7.
Affinity of anti-spike antibodies in SARS-CoV-2 patient plasma and its effect on COVID-19 antibody assays.
EBioMedicine
; 75: 103796, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34971970
8.
Specificity and Confirmation of SARS-CoV-2 Serological Test Methods in Emergency Department Populations across the United States.
J Appl Lab Med
; 2022 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35794234
9.
Affinity of anti-spike antibodies to three major SARS-CoV-2 variants in recipients of three major vaccines.
Commun Med (Lond)
; 2: 109, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36034646
10.
Awareness of SARS-CoV-2 Omicron Variant Infection Among Adults With Recent COVID-19 Seropositivity.
JAMA Netw Open
; 5(8): e2227241, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35976645
11.
Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel Disease.
Front Immunol
; 13: 880190, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35464463
12.
Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysis.
BMJ Open
; 12(5): e059994, 2022 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35613792
13.
Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2.
Nat Med
; 27(6): 981-984, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33795870
14.
The T-cell clonal response to SARS-CoV-2 vaccination in inflammatory bowel disease patients is augmented by anti-TNF therapy and often deficient in antibody-responders.
medRxiv
; 2021 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34909785
15.
Longitudinal SARS-CoV-2 mRNA Vaccine-Induced Humoral Immune Responses in Patients with Cancer.
Cancer Res
; 81(24): 6273-6280, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34759001
16.
Engineering of the hepatitis C virus helicase for enhanced seroreactivity.
J Virol Methods
; 264: 11-17, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30381240
17.
The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy.
Inflamm Bowel Dis
; 28(7): 1130-1133, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35397000